Skip to main content
Fig. 3 | BMC Women's Health

Fig. 3

From: Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial

Fig. 3

Evolution of the variables of primary efficacy taking or not Anastrozole: a VAS, % improvement by treatment. b % of cases with CA-125 > 35 UI/mL. c Ultrasound finding (TVU) in the CT under Anastrozole (15 patients). d Ultrasound finding (TVU) in the CT, no Anastrozole (16 patients). Normal or dysfunctional = findings of normal ovaries or with dysfunctional cyst (luteal)

Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us